Partnership Limited Associates Enterprise New Net Worth & Insider Trades

Partnership Limited Associates Enterprise New Proteostasis Therapeutics, Inc

As of November 29, 2019

What is Partnership Limited Associates Enterprise New's Net Worth?

The current estimated net worth of Proteostasis Therapeutics, Inc's Partnership Limited Associates Enterprise New is estimated to be about $953.7M . Partnership Limited Associates Enterprise New owns about 4,270,691 units of Proteostasis Therapeutics, Inc common stock. In the last 3 years at Proteostasis Therapeutics, Inc, Partnership Limited Associates Enterprise New has sold an estimated value of $3.23M worth.

What is Partnership Limited Associates Enterprise New's Past Insider Trading?

Partnership Limited Associates Enterprise New's largest purchase order was 2,000,000 units , worth over $10M on December 19, 2017. Partnership Limited Associates Enterprise New's largest sale order was 1,283,919 units , worth over $3.23M on November 29, 2019. In total, Partnership Limited Associates Enterprise New has made about 4 transactions over 3 years of their time at Proteostasis Therapeutics, Inc. Partnership Limited Associates Enterprise New usually trades in November, September, February and December, with the busiest year in 2016.

Partnership Limited Associates Enterprise New, Partnership Limited Partners NEA, NEA GP LLC, PETER BARRIS, FOREST BASKETT, PATRICK KERINS, SCOTT SANDELL

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Partnership Limited Associates Enterprise New's' Mailing Address?

  • Mailing address is 1119 St. Paul Street Baltimore MD 21202 MD

What are Proteostasis Therapeutics, Inc's Past Insider Trades?

Proteostasis Therapeutics, Inc's most recent insider trade came on November 29, 2019 by Partnership Limited Associates Enterprise New, Partnership Limited Partners Nea, Nea GP Llc, Peter Barris, Forest Baskett, Patrick Kerins and Scott Sandell who sold 1,283,919 units worth $3.23M . In the last 3 years, insiders at Proteostasis Therapeutics, Inc have sold an estimated value of $6.82M and bought an estimated value of $75.44M worth of shares. Insider trading is most common in February, with the busiest year in 2016. The most active traders at the company are Franklin Berger, Director,  Meenu Chhabra, President and CEO,  and Bihua Chen, Director .

PROTEOSTASIS THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1